Arrianna Marie Planey, Lisa P Spees, Caitlin B Biddell, Austin Waters, Emily P Jones, Hillary K Hecht, Donald Rosenstein, Stephanie B Wheeler
{"title":"癌症护理中旅行负担与经济困难的交集:范围审查。","authors":"Arrianna Marie Planey, Lisa P Spees, Caitlin B Biddell, Austin Waters, Emily P Jones, Hillary K Hecht, Donald Rosenstein, Stephanie B Wheeler","doi":"10.1093/jncics/pkae093","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In addition to greater delays in cancer screening and greater financial hardship, rural-dwelling cancer patients experience greater costs associated with accessing cancer care, including higher cumulative travel costs. This study aimed to identify and synthesize peer-reviewed research on the cumulative and overlapping costs associated with care access and utilization.</p><p><strong>Methods: </strong>A scoping review was conducted to identify relevant studies published after 1995 by searching 5 electronic databases: PubMed, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycInfo, and Healthcare Administration. Eligibility was determined using the PEO (Population, Exposure, and Outcomes) method, with clearly defined populations (cancer patients), exposures (financial hardship, toxicity, or distress; travel-related burdens), and outcomes (treatment access, treatment outcomes, health-related quality of life, and survival/mortality). Study characteristics, methods, and findings were extracted and summarized.</p><p><strong>Results: </strong>Database searches yielded 6439 results, of which 3366 were unique citations. Of those, 141 were eligible for full-text review, and 98 studies at the intersection of cancer-related travel burdens and financial hardship were included. Five themes emerged as we extracted from the full texts of the included articles: 1) Cancer treatment choices, 2) Receipt of guideline-concordant care, 3) Cancer treatment outcomes, 4) Health-related quality of life, and 5) Propensity to participate in clinical trials.</p><p><strong>Conclusions: </strong>This scoping review identifies and summarizes available research at the intersection of cancer care-related travel burdens and financial hardship. This review will inform the development of future interventions aimed at reducing the negative effects of cancer-care related costs on patient outcomes and quality of life.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519048/pdf/","citationCount":"0","resultStr":"{\"title\":\"The intersection of travel burdens and financial hardship in cancer care: a scoping review.\",\"authors\":\"Arrianna Marie Planey, Lisa P Spees, Caitlin B Biddell, Austin Waters, Emily P Jones, Hillary K Hecht, Donald Rosenstein, Stephanie B Wheeler\",\"doi\":\"10.1093/jncics/pkae093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In addition to greater delays in cancer screening and greater financial hardship, rural-dwelling cancer patients experience greater costs associated with accessing cancer care, including higher cumulative travel costs. This study aimed to identify and synthesize peer-reviewed research on the cumulative and overlapping costs associated with care access and utilization.</p><p><strong>Methods: </strong>A scoping review was conducted to identify relevant studies published after 1995 by searching 5 electronic databases: PubMed, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycInfo, and Healthcare Administration. Eligibility was determined using the PEO (Population, Exposure, and Outcomes) method, with clearly defined populations (cancer patients), exposures (financial hardship, toxicity, or distress; travel-related burdens), and outcomes (treatment access, treatment outcomes, health-related quality of life, and survival/mortality). Study characteristics, methods, and findings were extracted and summarized.</p><p><strong>Results: </strong>Database searches yielded 6439 results, of which 3366 were unique citations. Of those, 141 were eligible for full-text review, and 98 studies at the intersection of cancer-related travel burdens and financial hardship were included. Five themes emerged as we extracted from the full texts of the included articles: 1) Cancer treatment choices, 2) Receipt of guideline-concordant care, 3) Cancer treatment outcomes, 4) Health-related quality of life, and 5) Propensity to participate in clinical trials.</p><p><strong>Conclusions: </strong>This scoping review identifies and summarizes available research at the intersection of cancer care-related travel burdens and financial hardship. This review will inform the development of future interventions aimed at reducing the negative effects of cancer-care related costs on patient outcomes and quality of life.</p>\",\"PeriodicalId\":14681,\"journal\":{\"name\":\"JNCI Cancer Spectrum\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519048/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JNCI Cancer Spectrum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jncics/pkae093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkae093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:除了癌症筛查的更多延误和更大的经济困难之外,居住在农村的癌症患者在接受癌症治疗时还需要支付更多的相关费用,包括更高的累积旅行费用。本研究旨在确定和综合经同行评审的、与获得和利用医疗服务相关的累积和重叠成本的研究:通过搜索五个电子数据库,对 1995 年之后发表的相关研究进行了范围界定:PubMed、Scopus、Cumulative Index of Nursing and Allied Health Literature (CINAHL)、PsycInfo 和 Healthcare Administration。采用 PEO(人群、暴露和结果)方法确定研究资格,明确界定人群(癌症患者)、暴露(经济困难、毒性或痛苦;与旅行相关的负担)和结果(治疗机会、治疗结果、与健康相关的生活质量和存活率/死亡率)。对研究特点、方法和结果进行了提取和总结:结果:通过数据库检索获得了 6,439 条结果,其中 3,366 条为唯一引用。其中 141 篇符合全文审阅条件,98 篇与癌症相关的旅行负担和经济困难相关的研究被纳入其中。我们从收录文章的全文中提取出了五 (5) 个主题:(1) 癌症治疗选择;(2) 接受与指南一致的护理;(3) 癌症治疗结果;(4) 与健康相关的生活质量;(5) 参与临床试验的倾向:本范围界定综述确定并总结了与癌症护理相关的旅行负担和经济困难交叉点的现有研究。该综述将为今后制定旨在减少癌症治疗相关费用对患者预后和生活质量的负面影响的干预措施提供参考。
The intersection of travel burdens and financial hardship in cancer care: a scoping review.
Background: In addition to greater delays in cancer screening and greater financial hardship, rural-dwelling cancer patients experience greater costs associated with accessing cancer care, including higher cumulative travel costs. This study aimed to identify and synthesize peer-reviewed research on the cumulative and overlapping costs associated with care access and utilization.
Methods: A scoping review was conducted to identify relevant studies published after 1995 by searching 5 electronic databases: PubMed, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycInfo, and Healthcare Administration. Eligibility was determined using the PEO (Population, Exposure, and Outcomes) method, with clearly defined populations (cancer patients), exposures (financial hardship, toxicity, or distress; travel-related burdens), and outcomes (treatment access, treatment outcomes, health-related quality of life, and survival/mortality). Study characteristics, methods, and findings were extracted and summarized.
Results: Database searches yielded 6439 results, of which 3366 were unique citations. Of those, 141 were eligible for full-text review, and 98 studies at the intersection of cancer-related travel burdens and financial hardship were included. Five themes emerged as we extracted from the full texts of the included articles: 1) Cancer treatment choices, 2) Receipt of guideline-concordant care, 3) Cancer treatment outcomes, 4) Health-related quality of life, and 5) Propensity to participate in clinical trials.
Conclusions: This scoping review identifies and summarizes available research at the intersection of cancer care-related travel burdens and financial hardship. This review will inform the development of future interventions aimed at reducing the negative effects of cancer-care related costs on patient outcomes and quality of life.